International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions
Xavier Norel(Inserm), Lucie H. Clapp(The London College), Chengcan Yao(University of Edinburgh), Amel Bouhadoun(Inserm), Marie Goepp(Centre for Inflammation Research), Yukihiko Sugimoto(Kumamoto University), Hasanga D. Manikpurage(Inserm), Heba Abdelazeem(Inserm), Dan Longrois(Hôpital Bichat-Claude-Bernard), Amira Senbel(Inserm), Gülsev Özen(Istanbul University), Yasmine Amgoud(Inserm), Wesam Bassiouni(University of British Columbia), Salma Mani(Inserm), Ákos Heinemann(Medical University of Graz)
Cited by 47
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Comfort and patient-centred care without excessive sedation: the eCASH concept
|Intensive Care Medicine|2016|429
The Role of Prostaglandin E Receptor Subtypes (EP1, EP2, EP3, and EP4) in Bone Resorption: An Analysis Using Specific Agonists for the Respective EPs
|Endocrinology|2000|391
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Terlipressin for norepinephrine-resistant septic shock
|The Lancet|2002|259